Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
100 (46%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-LENOLTEC NO. 1 | 300MG 15MG 8MG | TABLET | Resolved | 2021-03-11 | 2021-03-25 | 135549 |
| TEVA-LENOLTEC NO. 1 | 300MG 15MG 8MG | TABLET | Resolved | 2021-04-08 | 2021-05-27 | 137206 |
| TEVA-LENOLTEC NO. 1 | 8MG 15MG 300MG | TABLET | Resolved | 2022-12-22 | 2023-01-19 | 179194 |
| TEVA-LENOLTEC NO. 1 | 8MG 15MG 300MG | TABLET | Resolved | 2022-06-03 | 2022-07-20 | 161931 |
| TEVA-LENOLTEC NO. 1 | 8MG 15MG 300MG | TABLET | Resolved | 2022-12-01 | 2023-01-19 | 176833 |
| TEVA-LENOLTEC NO. 1 | 300MG 15MG 8MG | TABLET | Resolved | 2020-05-14 | 2020-07-23 | 115199 |
| TEVA-LENOLTEC NO. 1 | 300MG 8MG 15MG | TABLET | Resolved | 2019-10-31 | 2020-07-23 | 97594 |
| TEVA-LENOLTEC NO. 1 | 300MG 8MG 15MG | TABLET | Resolved | 2019-11-28 | 2020-05-01 | 99856 |
| TEVA-LENOLTEC NO. 2 | 15MG 15MG 300MG | TABLET | Resolved | 2021-04-29 | 2021-06-10 | 138285 |
| TEVA-LENOLTEC NO. 2 | 300MG 15MG 15MG | TABLET | Resolved | 2020-06-25 | 2020-07-23 | 118951 |
| TEVA-LENOLTEC NO. 3 | 300MG 30MG 15MG | TABLET | Resolved | 2019-12-19 | 2020-01-25 | 101707 |
| TEVA-LENOLTEC NO. 3 | 300MG 30MG 15MG | TABLET | Resolved | 2024-04-18 | 2024-05-23 | 225477 |
| TEVA-LENOLTEC NO. 3 | 300MG 30MG 15MG | TABLET | Resolved | 2021-04-29 | 2021-05-06 | 138288 |
| TEVA-LENOLTEC NO. 3 | 15MG 30MG 300MG | TABLET | Resolved | 2020-04-16 | 2020-07-30 | 112376 |
| TEVA-LENOLTEC NO. 4 | 300MG 60MG | TABLET | Resolved | 2019-12-12 | 2020-01-25 | 101145 |
| TEVA-LENOLTEC NO. 4 | 300MG 60MG | TABLET | Resolved | 2020-06-25 | 2020-07-23 | 118928 |
| TEVA-LENOLTEC NO. 4 | 300MG 60MG | TABLET | Resolved | 2020-10-01 | 2020-10-22 | 125458 |
| TEVA-LENOLTEC NO. 4 | 60MG 300MG | TABLET | Actual shortage | 2025-04-24 | 2025-04-24 | 255672 |
| TEVA-LENOLTEC NO. 4 | 60MG 300MG | TABLET | Resolved | 2022-01-27 | 2022-02-25 | 153724 |
| TEVA-LENOLTEC NO. 4 | 60MG 300MG | TABLET | Resolved | 2022-03-24 | 2022-05-05 | 157259 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| METHOTREXATE SODIUM INJECTION | 25MG | SOLUTION | Discontinued | 2025-04-25 | 2025-04-25 | 255818 |
| METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION | 40MG | POWDER FOR SOLUTION | Discontinued | 2021-09-23 | 2021-09-23 | 146061 |
| NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-04-11 | 2019-04-11 | 81321 |
| NOVAMOXIN | 500MG | CAPSULE | Discontinued | 2017-06-27 | 2017-06-27 | 14046 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Discontinued | 2019-04-11 | 2019-04-11 | 81316 |
| NOVAMOXIN | 250MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104289 |
| NOVAMOXIN | 25MG | GRANULES FOR SUSPENSION | Discontinued | 2019-04-11 | 2019-04-11 | 81393 |
| NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-10-25 | 2019-10-26 | 97251 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
| NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
| NOVO-PROFEN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64920 |
| NOVO-PROFEN | 200MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81310 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 |